Results 21 to 30 of about 31,542 (255)

NEOVASCULARIZATION IN PROSTATIC ADENOCARCINOMA AS DETERMINED BY CD34: A RETROSPECTIVE STUDY

The Iraqi Journal of Medical Sciences, 2016
Background: Microvessel density is one of the variables that are thought to affect the natural history of prostatic carcinoma in as much as its degree influences tumor progression including the ability of invasion and metastasis.
Usama T Al-Badri, Sahira A Ali, Nabeel WRasheed   +2 more
doaj   +4 more sources

Study of CD117 Expression and Its Relationship with Benign Prostatic Hyperplasia and Gleason Score in Prostatic Adenocarcinoma [PDF]

Journal of Mazandaran University of Medical Sciences, 2023
Background and purpose: Prostate cancer is the second cause of cancer-related death in men. Early diagnosis and identification of prognostic factors help to predict clinical outcome and select the most effective treatment protocol in each patient.
Mehdi Rahmanpour, Mohammadreza Jalali Nadoushan   +1 more
doaj  

Incidental periprostatic schwannoma discovered during evaluation for prostatic adenocarcinoma

Urology Case Reports, 2020
Schwannomas of the prostate are exceedingly rare. We present a noteworthy case of a sporadic prostatic schwannoma diagnosed in conjunction with prostatic adenocarcinoma.A 60-year-old male presented with mild lower urinary tract symptoms and a prostate ...
Barbara Dietrick, Cole Friedes, Marissa J. White, Mohamad E. Allaf, Alexa R. Meyer   +4 more
doaj   +1 more source

Transformation of a prostatic adenocarcinoma into squamous cell carcinoma after luteinizing hormone-releasing hormone agonist and radiotherapy treatment

The Pan African Medical Journal, 2019
Squamous cell carcinoma of the prostate is rare and represents 0.5% to 1% of prostatic carcinomas. Transformation of prostatic adenocarcinoma into squamous cell carcinoma after LH-RH agonist intake has been reported in only 8 cases in the literature.
Hamza Ichaoui, Sonia Ben Nasr, Faten Gargouri, Aref Zribi, Amine Hermi, Sana Fendri, Mehdi Balti, Jihen Ayari, Ramzi Khiari, Issam Msakni, Nada Mansouri, Samir Ghozzi, Abderrazek Haddaoui   +12 more
doaj   +1 more source

A rare case of prostatic ductal adenocarcinoma presenting as papillary metastatic carcinoma of unknown primary: A case report and review of the literature

Human Pathology: Case Reports, 2016
Prostatic ductal adenocarcinoma is an uncommon form of prostatic carcinoma. We report a case of a 63-year-old man who presented with non-infective thrombotic (marantic) endocarditis and an incidental finding of a destructive lesion in the left iliac ...
Erik R. Washburn, MD, Grace W. Weyant, MD, Ximing J. Yang, MD, PhD, Zhaohai Yang, MD, PhD   +3 more
doaj   +1 more source

Prostate carcinoma metastatic to the skin as an extrammamary Paget’s disease

Diagnostic Pathology, 2012
Aim The current paper describes a case of prostatic adenocarcinoma metastatic to the skin presenting as an extrammamary Paget's disease, a very rare and poorly characterised morphological entity. We report a case of prostatic carcinoma metastatic to skin
Petcu Eugen, Gonzalez-Serva Aldo, Wright Robert G, Slevin Mark, Brinzaniuc Klara   +4 more
doaj   +1 more source

COMP–PMEPA1 axis promotes epithelial‐to‐mesenchymal transition in breast cancer cells

Molecular Oncology, EarlyView.
This study reveals that cartilage oligomeric matrix protein (COMP) promotes epithelial‐to‐mesenchymal transition (EMT) in breast cancer. We identify PMEPA1 (protein TMEPAI) as a novel COMP‐binding partner that mediates EMT via binding to the TSP domains of COMP, establishing the COMP–PMEPA1 axis as a key EMT driver in breast cancer.
Konstantinos S. Papadakos, Gilar Gorji‐bahri, Lejla Gradjan, Julia Zajac, Kacper Gil, Yvonne Thokozile Nduku, Anna M. Blom   +6 more
wiley   +1 more source

Metastatic Prostatic Acinar Adenocarcinoma Presenting as a Penile Malignant Tumour: A Case Report [PDF]

National Journal of Laboratory Medicine
Penile metastasis from occult prostatic acinar adenocarcinoma is extremely rare and has been described in only a few case reports in the literature. The incidence of metastasis from known prostatic adenocarcinoma to the penis is less than 0.3%.
Gwendolyn Fernandes, Kaustubh Vilasrao Kharche, Amey Rojekar   +2 more
doaj   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

Molecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau, Lilian G. Zhai, Ryunosuke Hoshi, Zackary Rousseau, Abraam Zakhary, Yin Fang Wu, Rola M. Saleeb, Heyu Ni, Kelsie L. Thu   +8 more
wiley   +1 more source

Diagnostic utility of immunohistochemical marker prostein for evaluation of primary and metastatic prostatic carcinomas

Indian Journal of Pathology and Microbiology, 2020
Context: The diagnosis of prostatic adenocarcinoma on histopathology depends on architectural and cytomorphological features supported by immunohistochemistry (IHC).
Gowri Garudadri, B Vishal Rao, Challa Sundaram, Daphne Fonseca, S Sudha Murthy, Rakesh Sharma, T Subramanyeshwar Rao   +6 more
doaj   +1 more source